Why UnitedHealth Stock Popped on Wednesday

Source Motley_fool

Key Points

  • An analyst raised his price target on the health insurer by 14%.

  • He also kept his buy recommendation intact.

  • 10 stocks we like better than UnitedHealth Group ›

An analyst's price target increase for UnitedHealth Group (NYSE: UNH) stock was taken to heart by investors on Wednesday. Following news of the boost, they collectively pushed the large health insurer's stock up by almost 5% that trading session.

14% more optimistic

The person behind the raise was Wolfe Research prognosticator Justin Lake. Well before market open that day, he upped his price target on UnitedHealth to $375 per share from his previous $330. He maintained his outperform (i.e., buy) recommendation as he did so.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Two people participating in a telehealth session.

Image source: Getty Images.

According to reports, the analyst is bullish on the future of both the company's foundational UnitedHealthcare insurance operations and its Optum healthcare services and tech unit.

He believes that UnitedHealthcare will be able to improve its margins to meet management's target levels. Meanwhile, Optum has good potential to post meaningful growth going forward.

Looks like a buy on weakness

Collectively, analysts are modeling improvements on both the top and bottom lines for UnitedHealth's 2026. Their consensus for revenue growth that year is 2% (to just over $457 billion), while that for per-share earnings is an encouraging 9% (to $17.71).

Lake's rosy take on the stock aside, UnitedHealth hasn't been a popular stock lately. It's facing numerous challenges these days. To name two significant ones, it's coping with a surge in costs related to its Medicare Advantage business, and Affordable Care Act (i.e., Obamacare) subsidies are weeks away from expiration.

That said, the company remains a powerhouse in its sector, and I believe these problems are surmountable. Given that, I'd consider buying its stock at the current weakened price.

Should you invest $1,000 in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $589,717!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,111,405!*

Now, it’s worth noting Stock Advisor’s total average return is 1,018% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of December 1, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
US Dollar's Decline Predicted in 2026: Morgan Stanley's Outlook on Currency VolatilityMorgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
Author  Mitrade
Nov 25, Tue
Morgan Stanley forecasts a 5% drop in the dollar by mid-2026, attributed to continued Fed rate cuts. A recovery may follow as growth improves and funding currency dynamics shift favorably toward the euro and Swiss franc.
placeholder
Silver Extends Record Rally on Supply Squeeze and Rate-Cut BetsSilver surged to a new high on Monday, extending a record-breaking rally as traders bet on persistent supply tightness and rising expectations for U.S. interest-rate cuts. Gold held steady.
Author  Mitrade
Dec 01, Mon
Silver surged to a new high on Monday, extending a record-breaking rally as traders bet on persistent supply tightness and rising expectations for U.S. interest-rate cuts. Gold held steady.
placeholder
U.S. Dollar Weakened by Dismal Manufacturing Data; Rate Cut Expected This MonthThe U.S. dollar remains under pressure as disappointing manufacturing data heightens expectations for a rate cut by the Federal Reserve at its upcoming meeting on December 10. Manufacturing PMI fell to 48.2, marking the ninth consecutive month of contraction.
Author  Mitrade
Dec 02, Tue
The U.S. dollar remains under pressure as disappointing manufacturing data heightens expectations for a rate cut by the Federal Reserve at its upcoming meeting on December 10. Manufacturing PMI fell to 48.2, marking the ninth consecutive month of contraction.
placeholder
Asian Shares Rebound as Wall Street Gains and Fed Rate Cut Anticipation LoomsAsian markets stabilized thanks to Wall Street's recovery, with Bitcoin regaining $90,000. Investor focus shifts to a potential Federal Reserve rate cut, improving overall market sentiment ahead of December.
Author  Mitrade
21 hours ago
Asian markets stabilized thanks to Wall Street's recovery, with Bitcoin regaining $90,000. Investor focus shifts to a potential Federal Reserve rate cut, improving overall market sentiment ahead of December.
placeholder
Silver Pulls Back From Record High as Investors Await US Economic DataSilver prices fell on Wednesday, retreating from the previous session’s all-time peak, as traders turned cautious ahead of key U.S. economic reports that could influence the Federal Reserve’s policy path.
Author  Mitrade
16 hours ago
Silver prices fell on Wednesday, retreating from the previous session’s all-time peak, as traders turned cautious ahead of key U.S. economic reports that could influence the Federal Reserve’s policy path.
goTop
quote